Nivulia Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 7 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 38.45%
- Profit Growth 100.36%
- Ebitda -68.75%
- Net Worth 4.79%
- Total Assets 96.35%
About Nivulia Lifesciences
Nivulia Lifesciences Private Limited (NLPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 March 2017 (Seven years and ten months 18 days old ). Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ananth, Thavasi Muthupandi, Jamesha Thajudeen, and One other member serve as directors at the Company.
Company Details
-
Location
Coimbatore, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999TZ2017PTC028737
-
Company No.
028737
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Mar 2017
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Nivulia Lifesciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ananth
|
Director | 30-Mar-2017 | Current |
|
Thavasi Muthupandi
|
Director | 30-Mar-2017 | Current |
|
Jamesha Thajudeen
|
Director | 30-Mar-2017 | Current |
|
Kannusamy Mariappan
|
Director | 30-Mar-2017 | Current |
Financial Performance of Nivulia Lifesciences.
Nivulia Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 38.45% increase. The company also saw a substantial improvement in profitability, with a 100.36% increase in profit. The company's net worth moved up by a moderate rise of 4.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nivulia Lifesciences?
Unlock access to Nivulia Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nivulia Lifesciences?
Unlock and access historical data on people associated with Nivulia Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nivulia Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nivulia Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.